DIRAS3 and cancer: Meanwhile, Sutton MN et al. previously highlighted that DIRAS3 can directly form a heteromeric interaction with RAS, wherein disrupting RAS aggregation and blocking Raf kinase activation, thereby inhibiting RAS/MAPK signaling to inhibit cancer cell growth [37].